These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26163145)

  • 1. Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
    Riepe MW; Walther B; Vonend C; Beer AJ
    BMC Psychiatry; 2015 Jul; 15():157. PubMed ID: 26163145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.
    Desgranges B; Baron JC; Lalevée C; Giffard B; Viader F; de La Sayette V; Eustache F
    Brain; 2002 May; 125(Pt 5):1116-24. PubMed ID: 11960900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
    Kim SH; Seo SW; Yoon DS; Chin J; Lee BH; Cheong HK; Han SH; Na DL
    Dement Geriatr Cogn Disord; 2010; 29(3):213-23. PubMed ID: 20332639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    Weissberger GH; Melrose RJ; Fanale CM; Veliz JV; Sultzer DL
    J Alzheimers Dis; 2017; 60(2):707-719. PubMed ID: 28869474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.
    Tomadesso C; Perrotin A; Mutlu J; Mézenge F; Landeau B; Egret S; de la Sayette V; Jonin PY; Eustache F; Desgranges B; Chételat G
    Neuroimage Clin; 2015; 8():473-82. PubMed ID: 26106572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
    Auning E; Selnes P; Grambaite R; Šaltytė Benth J; Haram A; Løvli Stav A; Bjørnerud A; Hessen E; Hol PK; Muftuler løndalen A; Fladby T; Aarsland D
    Acta Psychiatr Scand; 2015 Feb; 131(2):139-47. PubMed ID: 25346330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.